Guidelines

Is 8 Minutes of Exercise Enough?

A mere eight minutes of exercise a day – 54 minutes a week – is enough to lower the risk of early death and heart disease. 

In a study published in the European Heart Journal, scientists examined data from fitness trackers worn by nearly 72k people in the UK. After a 6-year mean follow-up, researchers found that eight minutes of vigorous physical activity a day lowered the risk of early death by 36%, and the risk of CVD by 35%. 

Here’s a sample of how different weekly exercise lengths correlated with mortality and cardiovascular disease incidents : 

  • 15 minutes/week → 16-18% lower all-cause mortality
  • 20 minutes/week → 40% lower CVD mortality
  • Further beneficial associations observed for up to 50-57 minutes per week. 

The people who exercised even more saw greater improvements, but the protective effects of vigorous exercise began to plateau around 54 minutes. 

The Takeaway

The CDC recommends at least 150 minutes of moderate intensity exercise or 75 minutes of vigorous exercise each week. But still, a majority of Americans fail to meet these guidelines. Perhaps aiming for eight minutes of intense movement each day may help make exercise more accessible and achievable.

It’s hard to keep up with all the data pertaining to optimal exercise routines for health and longevity. But all studies seem to agree that getting your body moving – even for just a handful of minutes – has life-changing effects. 

Get twice-weekly insights on the biggest stories shaping cardiology.

You might also like

Cardiac Imaging June 16, 2025

Beyond Hardware: Is AI the Answer to Making Cardiac Imaging more Accessible? June 16, 2025

Sponsored by Philips Healthcare Cardiac imaging has traditionally improved through hardware advances, enabling the speed needed for high-quality images. However, hardware is rapidly reaching its physical limitations in suppressing cardiac motion and represents a large financial investment. Today, software and AI are driving the next leap in cardiac image quality and motion control – offering […]

Cardiology Pharmaceuticals June 12, 2025

FDA Approves a New BP Triple Polypill June 12, 2025

Bringing a more effective BP therapy to the U.S. market, the FDA approved George Medicines’ triple therapy polypill called Widaplik for patients with hypertension, making it the first of its kind to go to market in the U.S. Widaplik’s approval stems from two studies, including one comparing the polypill against placebo as an initial treatment […]

Cardiology Pharmaceuticals June 12, 2025

Pharmacologic Preconditioning to Improve Outcomes in Patients Undergoing Cardiac Surgery  June 12, 2025

The majority of patients undergoing cardiac surgery, especially those on cardiopulmonary bypass (CPB), experience post-operative complications such as new-onset atrial fibrillation (POAF) and acute kidney injury (AKI), largely driven by oxidative stress and inflammation.   Several approaches have been explored to reduce complications following cardiac surgery, however, a clinically meaningful impact has yet to be realized.  […]

You might also like..

Select All

You're signed up!

It's great to have you as a reader. Check your inbox for a welcome email.

-- The Cardiac Wire Team

You're all set!